Zobrazeno 1 - 6
of 6
pro vyhledávání: '"YaYi Peng"'
Autor:
Pedro Horna, Matthew J. Weybright, Mathieu Ferrari, Dennis Jungherz, YaYi Peng, Zulaikha Akbar, F. Tudor Ilca, Gregory E. Otteson, Jansen N. Seheult, Janosch Ortmann, Min Shi, Paul M. Maciocia, Marco Herling, Martin A. Pule, Horatiu Olteanu
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract The diagnosis of leukemic T-cell malignancies is often challenging, due to overlapping features with reactive T-cells and limitations of currently available T-cell clonality assays. Recently developed therapeutic antibodies specific for the
Externí odkaz:
https://doaj.org/article/48857f99de054473875e959f04e0679a
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundWith the development of radiotherapy technology, radiotherapy has been increasingly used to treat primary hepatocellular carcinoma (HCC). However, due to radioresistance and the intolerance of the adjacent organs to radiation, the effects o
Externí odkaz:
https://doaj.org/article/0803226271014d13981246b84bac439d
Autor:
Nils Goehringer, Yayi Peng, Bianca Nitzsche, Hannah Biermann, Rohan Pradhan, Rainer Schobert, Marco Herling, Michael Höpfner, Bernhard Biersack
Publikováno v:
Pharmaceuticals, Vol 14, Iss 12, p 1319 (2021)
The development of new anticancer drugs is necessary in order deal with the disease and with the drawbacks of currently applied drugs. Epigenetic dysregulations are a central hallmark of cancerogenesis and histone deacetylases (HDACs) emerged as prom
Externí odkaz:
https://doaj.org/article/368026ab9c6c4248b0734b1f915067ac
Autor:
Nils, Goehringer, Bernhard, Biersack, Yayi, Peng, Rainer, Schobert, Marco, Herling, Andi, Ma, Bianca, Nitzsche, Michael, Höpfner
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 8432, p 8432 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 16
International Journal of Molecular Sciences
Volume 22
Issue 16
New chimeric inhibitors targeting the epidermal growth factor (EGFR) and histone deacetylases (HDACs) were synthesized and tested for antineoplastic efficiency in solid cancer (prostate and hepatocellular carcinoma) and leukemia/lymphoma cell models.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::760856fcda2618e23e7fa4cfc6666a15
https://www.mdpi.com/1422-0067/22/16/8432
https://www.mdpi.com/1422-0067/22/16/8432
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
BackgroundWith the development of radiotherapy technology, radiotherapy has been increasingly used to treat primary hepatocellular carcinoma (HCC). However, due to radioresistance and the intolerance of the adjacent organs to radiation, the effects o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d557e17c99f0892a89006be27b0cae6
http://europepmc.org/articles/PMC7943860
http://europepmc.org/articles/PMC7943860
Publikováno v:
SSRN Electronic Journal.
Background: With the development of radiotherapy technology, Radiotherapy has been used increasingly to treat primary hepatocellular carcinoma (HCC). But due to the radioresistance and the intolerance of the adjacent organs, the effect of radiotherap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa1a3a6290eaf899854e5404295f0ef7
https://doi.org/10.2139/ssrn.3384864
https://doi.org/10.2139/ssrn.3384864